NCT05860803Recruiting
Breathing Training and Exercise Capacity in Non-CFB
Home-based, Digitally Delivered Breathing Training in People With Non-cystic Fibrosis Bronchiectasis: A Randomized Control Trial
Source: ClinicalTrials.gov · Last updated 6 Jan 2026
Brief summary (registry, in English)
The purpose of this research is to investigate whether a home-based and health coach supported specific breathing and respiratory muscle training program improves the ability to exercise, the function of the lungs and breathing muscles, and general clinical status in people with non-cystic fibrosis bronchiectasis (non-CFB).
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- First submitted
- 8 May 2023
- Start date
- 15 Jan 2024
- Primary completion date
- 1 Dec 2026
- Lead sponsor
- Mayo Clinic
- Diseases
- Cystic fibrosis
- NCT number
- NCT05860803
What you commit to
- Study type: Interventional
- Planned participants: 50
- From 15 Jan 2024 to the primary completion date, 1 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Acute exacerbation(s) within 3-weeks prior to study commencement.
- Participation within a pulmonary rehabilitation program within 6-months prior to study commencement.
Other illness
- Presence of significant coexisting disease, neurological conditions, and/or orthopedic complications that affect ability to undertake exercise.
- Presence of advanced heart failure.
Other
- Current use of antibiotics.
Who the study is looking for
- Mayo Clinic patient with confirmed diagnosis of Non-Cystic Fibrosis Bronchiectasis (non-CFB): Non-CFB as confirmed by clinical history, including cough, shortness of breath, exertional dyspnea, pulmonary function tests, and high-resolution computed tomography. Patients will be considered clinically stable if there is no evidence of an exacerbation or change(s) in medical therapy in the previous three weeks.
- Able and willing to provide informed consent to participate in the study.
Age in the registry: 21 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mayo Clinic Florida Coordinator of this site? Confirm its status | Jacksonville | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.